Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Lymphatic Metastasis 1Laryngeal Neoplasms 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1Breast Cancer Radiotherapy 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Prednisone 9Pemetrexed 9Epoetin Alfa 9venetoclax 8atezolizumab 8Fentanyl 8Drug Therapy 8Doxorubicin 8Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Radiotherapy, Adjuvant × Clear all
NCT00128817 2013-01-23

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Tata Memorial Hospital

Phase 3 Terminated
900 enrolled
Head & Neck

Laryngeal Diseases, Laryngeal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡